The effect of marital status on the survival of patients with multiple myeloma

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics 2018. CA Cancer J Clin. 2018;68:7–30.
   PubMed Web of Science ®Google Scholar
• Al Hamed R, Bazarbachi AH, Malard F, et al. Current status of autologous stem cell transplantation for multiple myeloma. Blood Cancer J. 2019;9:44.
   PubMed Web of Science ®Google Scholar
• Attal M, Harousseau JL, Leyvraz S, et al. Maintenance therapy with thalidomide improves survival in patients with multiple myeloma. Blood. 2006;108:3289–3294.
   PubMed Web of Science ®Google Scholar
• Richardson PG, Blood E, Mitsiades CS, et al. A randomized phase 2 study of lenalidomide therapy for patients with relapsed or relapsed and refractory multiple myeloma. Blood. 2006;108:3458–3464.
   PubMed Web of Science ®Google Scholar
• Kumar S, Flinn I, Richardson PG, et al. Randomized, multicenter, phase 2 study (EVOLUTION) of combinations of bortezomib, dexamethasone, cyclophosphamide, and lenalidomide in previously untreated multiple myeloma. Blood. 2012;119:4375–4382.
   PubMed Web of Science ®Google Scholar
• Costa LJ, Brill IK, Omel J, et al. Recent trends in multiple myeloma incidence and survival by age, race, and ethnicity in the United States. Blood Adv. 2017;1:282–287.
   PubMed Web of Science ®Google Scholar
• Fakhri B, Fiala MA, Tuchman SA, et al. Undertreatment of older patients with newly diagnosed multiple myeloma in the era of novel therapies. Clin Lymphoma Myeloma Leuk. 2018;18:219–224.
   PubMed Web of Science ®Google Scholar
• Fiala MA, Wildes TM, Vij R. Racial disparities in the utilization of novel agents for frontline treatment of multiple myeloma. Clin Lymphoma Myeloma Leuk. 2020;20:647–651.
   PubMed Web of Science ®Google Scholar
• Turesson I, Bjorkholm M, Blimark CH, et al. Rapidly changing myeloma epidemiology in the general population: increased incidence, older patients, and longer survival. Eur J Haematol. 2018;101:237–244.
   Web of Science ®Google Scholar
• Osazuwa-Peters N, Christopher KM, Cass LM, et al. What's love Got to do with it? marital status and survival of head and neck cancer. Eur J Cancer Care (Engl). 2019;28:e13022.
   PubMed Web of Science ®Google Scholar
• Jin JJ, Wang W, Dai FX, et al. Marital status and survival in patients with gastric cancer. Cancer Med. 2016;5:1821–1829.
   PubMed Web of Science ®Google Scholar
• Wu W, Fang D, Shi D, et al. Effects of marital status on survival of hepatocellular carcinoma by race/ethnicity and gender. Cancer Manag Res. 2018;10:23–32.
   PubMedGoogle Scholar
• Aizer AA, Chen MH, McCarthy EP, et al. Marital status and survival in patients with cancer. J Clin Oncol. 2013;31:3869–3876.
   PubMed Web of Science ®Google Scholar
• Goodwin JS, Hunt WC, Key CR, et al. The effect of marital status on stage, treatment, and survival of cancer patients. JAMA. 1987;258:3125–3130.
   PubMed Web of Science ®Google Scholar
• Uchino BN. Social support and health: a review of physiological processes potentially underlying links to disease outcomes. J Behav Med. 2006;29:377–387.
   PubMed Web of Science ®Google Scholar
• Zhao J, Su L, Zhong J. Risk factors for cancer-specific mortality and cardiovascular mortality in patients With diffuse large B-cell lymphoma. Clin Lymphoma Myeloma Leuk. 2020;20:e858–ee63.
   PubMed Web of Science ®Google Scholar
• Uno H, Cai T, Pencina MJ, et al. On the C-statistics for evaluating overall adequacy of risk prediction procedures with censored survival data. Stat Med. 2011;30:1105–1117.
   PubMed Web of Science ®Google Scholar
• Crowson CS, Atkinson EJ, Therneau TM. Assessing calibration of prognostic risk scores. Stat Methods Med Res. 2016;25:1692–1706.
   PubMed Web of Science ®Google Scholar
• Ailawadhi S, Frank RD, Sharma M, et al. Trends in multiple myeloma presentation, management, cost of care, and outcomes in the medicare population: A comprehensive look at racial disparities. Cancer. 2018;124:1710–1721.
   PubMed Web of Science ®Google Scholar
• Ailawadhi S, Aldoss IT, Yang D, et al. Outcome disparities in multiple myeloma: a SEER-based comparative analysis of ethnic subgroups. Br J Haematol. 2012;158:91–98.
   PubMed Web of Science ®Google Scholar
• Costa LJ, Zhang MJ, Zhong X, et al. Trends in utilization and outcomes of autologous transplantation as early therapy for multiple myeloma. Biol Blood Marrow Transplant. 2013;19:1615–1624.
   PubMed Web of Science ®Google Scholar
• Waxman AJ, Mink PJ, Devesa SS, et al. Racial disparities in incidence and outcome in multiple myeloma: a population-based study. Blood. 2010;116:5501–5506.
   PubMed Web of Science ®Google Scholar
• Ailawadhi S, Parikh K, Abouzaid S, et al. Racial disparities in treatment patterns and outcomes among patients with multiple myeloma: a SEER-medicare analysis. Blood Adv. 2019;3:2986–2994.
   PubMed Web of Science ®Google Scholar
• Ailawadhi S, Jacobus S, Sexton R, et al. Disease and outcome disparities in multiple myeloma: exploring the role of race/ethnicity in the cooperative group clinical trials. Blood Cancer J. 2018;8:67.
   PubMed Web of Science ®Google Scholar
• Fiala MA, Wildes TM. Racial disparities in treatment use for multiple myeloma. Cancer. 2017;123:1590–1596.
   PubMed Web of Science ®Google Scholar
• Fiala MA, Finney JD, Liu J, et al. Socioeconomic status is independently associated with overall survival in patients with multiple myeloma. Leuk Lymphoma. 2015;56:2643–2649.
   PubMed Web of Science ®Google Scholar
• Costa LJ, Brill IK, Brown EE. Impact of marital status, insurance status, income, and race/ethnicity on the survival of younger patients diagnosed with multiple myeloma in the United States. Cancer. 2016;122:3183–3190.
   PubMed Web of Science ®Google Scholar
• Evans LA, Go R, Warsame R, et al. The impact of socioeconomic risk factors on the survival outcomes of patients with newly diagnosed multiple myeloma: A cross-analysis of a population-based registry and a tertiary care center. Clin Lymphoma Myeloma Leuk. 2021;21:451–460.
   PubMed Web of Science ®Google Scholar
• Woods LM, Rachet B, Coleman MP. Origins of socio-economic inequalities in cancer survival: a review. Ann Oncol. 2006;17:5–19.
   PubMed Web of Science ®Google Scholar
• Rajkumar SV. Treatment of multiple myeloma. Nat Rev Clin Oncol. 2011;8:479–491.
   PubMed Web of Science ®Google Scholar
• Cairney J, Boyle M, Offord DR, et al. Stress, social support and depression in single and married mothers. Soc Psychiatry Psychiatr Epidemiol. 2003;38:442–449.
   PubMed Web of Science ®Google Scholar
• Goldzweig G, Andritsch E, Hubert A, et al. Psychological distress among male patients and male spouses: what do oncologists need to know? Ann Oncol. 2010;21:877–883.
   PubMed Web of Science ®Google Scholar
• Zimmaro LA, Sephton SE, Siwik CJ, et al. Depressive symptoms predict head and neck cancer survival: examining plausible behavioral and biological pathways. Cancer. 2018;124:1053–1060.
   PubMed Web of Science ®Google Scholar
• Aizer AA, Paly JJ, Zietman AL, et al. Multidisciplinary care and pursuit of active surveillance in low-risk prostate cancer. J Clin Oncol. 2012;30:3071–3076.
   PubMedGoogle Scholar
• Molassiotis A, Wilson B, Blair S, et al. Living with multiple myeloma: experiences of patients and their informal caregivers. Support Care Cancer. 2011;19:101–111.
   PubMed Web of Science ®Google Scholar
• Weissman MM, Bland RC, Canino GJ, et al. Cross-national epidemiology of major depression and bipolar disorder. JAMA. 1996;276:293–299.
   PubMed Web of Science ®Google Scholar
• Sklar LS, Anisman H. Stress and coping factors influence tumor growth. Science. 1979;205:513–515.
   PubMed Web of Science ®Google Scholar
• Antoni MH, Dhabhar FS. The impact of psychosocial stress and stress management on immune responses in patients with cancer. Cancer. 2019;125:1417–1431.
   PubMed Web of Science ®Google Scholar